Extended Longevity Supplements for Aging

Phase 2

Waitlist Available

Research Sponsored by TruDiagnostic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up testing will compare the change in results after completion of intervention with baseline

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a treatment plan called the Extended Longevity Protocol, which aims to slow down aging. It focuses on 15 healthy individuals to see if it can make them age more slowly and stay healthier. The protocol works by addressing nine different factors that contribute to aging.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ testing will compare the change in results after completion of intervention with baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~testing will compare the change in results after completion of intervention with baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and testing will compare the change in results after completion of intervention with baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Epigenetic Age

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: ExtractsExperimental Treatment1 Intervention

The ingredients found in these serums are all naturally occurring ingredients extracted from a variety of plant species: Pinetonal, Thyvolve, Telogenic, Sentophagy, Inflasolve, Stemegenis, and CMEnhance

Do I qualify?Apply below to find out